Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Naltrexone intranasal - Opiant Pharmaceuticals

Next Previous
X
Search
Drug Profile

Naltrexone intranasal - Opiant Pharmaceuticals

Alternative Names: INDV-4002; OPNT 002

Latest Information Update: 06 Mar 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Opiant Pharmaceuticals
  • Class Anti-inflammatories; Antineoplastics; Antivirals; Cyclopropanes; Drug withdrawal therapies; Ethers; Eye disorder therapies; Irritable bowel syndrome therapies; Ketones; Morphinans; Non-opioid analgesics; Small molecules
  • Mechanism of Action Opioid delta receptor antagonists; Opioid mu receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Alcoholism

Most Recent Events

  • 02 Mar 2023 Opiant Pharmaceuticals has been acquired by Indivior
  • 08 Dec 2022 Naltrexone intranasal is still in phase II trials for Alcoholism in United Kingdom and Hungary (Opiant Pharmaceuticals pipeline, December 2022)
  • 14 Nov 2022 Opiant Pharmaceuticals completes enrolment in phase II clinical trial in Alcoholism in United Kingdom and Hungary (Intranasal) (EudraCT2019-002859-42)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top